Advertisement

Topics

Galectin Offers Subgroup Approach For Struggling NASH Candidate

12:59 EST 6 Dec 2017 | SCRIP

Having failed to meet its primary endpoint in consecutive Phase II studies, Galectin hopes to move GR-MD-02 forward in NASH...

      

Related Stories

 

Original Article: Galectin Offers Subgroup Approach For Struggling NASH Candidate

NEXT ARTICLE

More From BioPortfolio on "Galectin Offers Subgroup Approach For Struggling NASH Candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...